|
INPP5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.050110E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.618700E-03 |
| Normal-vs-Stage2 |
3.693400E-01 |
| Normal-vs-Stage3 |
5.152200E-04 |
| Normal-vs-Stage4 |
1.717990E-02 |
| Stage1-vs-Stage2 |
1.261630E-01 |
| Stage1-vs-Stage3 |
2.506600E-01 |
| Stage1-vs-Stage4 |
6.018000E-01 |
| Stage2-vs-Stage3 |
2.846300E-02 |
| Stage2-vs-Stage4 |
1.448780E-01 |
| Stage3-vs-Stage4 |
8.238600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.768220E-02 |
| Normal-vs-AfricanAmerican |
1.787880E-02 |
| Normal-vs-Asian |
5.619100E-03 |
| Caucasian-vs-AfricanAmerican |
7.242600E-01 |
| Caucasian-vs-Asian |
1.464410E-01 |
| AfricanAmerican-vs-Asian |
1.918030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.105000E-03 |
| Normal-vs-Female |
1.433170E-01 |
| Male-vs-Female |
7.499500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.377800E-02 |
| Normal-vs-Extreme_Weight |
9.740700E-03 |
| Normal-vs-Obese |
2.312000E-02 |
| Normal-vs-Extreme_Obese |
5.031600E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.182200E-01 |
| Normal_Weight-vs-Obese |
9.250600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.912800E-01 |
| Extreme_Weight-vs-Obese |
6.407000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.969000E-01 |
| Obese-vs-Extreme_Obese |
6.992200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.280200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.958500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.400300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.000100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.720000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.670400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.049220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.444400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.198230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.298400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.400400E-02 |
| Normal-VS-Type2 PRCC |
1.58862999999343E-05 |
| Normal-VS-KIRP CIMP |
3.942300E-02 |
| Normal-VS-Unclassified PRCC |
5.179200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.410400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.605400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.143600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.803800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.380000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.445000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.226300E-04 |
| Normal-vs-N1 |
3.864900E-03 |
| Normal-vs-N2 |
2.990200E-01 |
| N0-vs-N1 |
9.252600E-01 |
| N0-vs-N2 |
6.645600E-01 |
| N1-vs-N2 |
6.680000E-01 |
|
|
